Full article: Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up
![PDF) Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register – a validation study PDF) Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register – a validation study](https://www.researchgate.net/profile/Gabriella_Broems/publication/349625773/figure/fig2/AS:997948536139778@1614940880829/a-Infliximab-treatment-start-in-reviewed-medical-records-vs-registers-n-14-1265_Q320.jpg)
PDF) Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register – a validation study
![PDF) Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register – a validation study PDF) Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register – a validation study](https://i1.rgstatic.net/publication/349625773_Capturing_biologic_treatment_for_IBD_in_the_Swedish_Prescribed_Drug_Register_and_the_Swedish_National_Patient_Register_-_a_validation_study/links/60420acaa6fdcc9c78124acf/largepreview.png)